BioXcel Therapeutics Company
Utilizes AI to identify and develop new applications for existing drugs or clinical candidates, focusing on neuroscience and immuno-oncology.
.png)
Total Funding:
Public (IPO 2018)
Founded Date:
2017
Industry:
Drug Repurposing
Employee Number:
100
Headquarters:
USA